CLINICAL TRIALS PROFILE FOR DEPAKOTE ER
✉ Email this page to a colleague
All Clinical Trials for DEPAKOTE ER
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00005015 ↗ | Treatment of Depression in Youth With Bipolar Disorders | Terminated | National Institute of Mental Health (NIMH) | Phase 3 | 1969-12-31 | THIS STUDY HAS BEEN DISCONTINUED. The study is designed to evaluate the safety and efficacy of fluoxetine for treating children and adolescents with Bipolar Disorder who are experiencing an episode of major depression while being treated with a mood stabilizer. The study involves a 2-week assessment period. Patients who are on stable, therapeutic doses of lithium or valproate and continue to have depression will be randomized to a 12-week treatment of fluoxetine or placebo. Those who respond favorably to treatment will be followed openly for an 18-week continuation phase. |
| NCT00048802 ↗ | Treatment and Outcome of Early Onset Bipolar Disorder | Completed | National Institute of Mental Health (NIMH) | Phase 4 | 2002-08-01 | This study will compare the effectiveness in the maintenance of continuing adjunctive atypical antipsychotic medication compared to traditional mood stabilizer(s) alone in the maintenance treatment of adolescents with bipolar disorder. |
| NCT00048802 ↗ | Treatment and Outcome of Early Onset Bipolar Disorder | Completed | Northwell Health | Phase 4 | 2002-08-01 | This study will compare the effectiveness in the maintenance of continuing adjunctive atypical antipsychotic medication compared to traditional mood stabilizer(s) alone in the maintenance treatment of adolescents with bipolar disorder. |
| NCT00057681 ↗ | Study of Outcome and Safety of Lithium, Divalproex and Risperidone for Mania in Children and Adolescents | Completed | National Institute of Mental Health (NIMH) | Phase 3 | 2003-02-01 | This study will evaluate the effectiveness of the medications, lithium (Eskalith®), valproate (Depakote®), and risperidone (Risperdal®) in treating children and adolescents with bipolar disorder or symptoms of mania. |
| NCT00057681 ↗ | Study of Outcome and Safety of Lithium, Divalproex and Risperidone for Mania in Children and Adolescents | Completed | Washington University School of Medicine | Phase 3 | 2003-02-01 | This study will evaluate the effectiveness of the medications, lithium (Eskalith®), valproate (Depakote®), and risperidone (Risperdal®) in treating children and adolescents with bipolar disorder or symptoms of mania. |
| NCT00060905 ↗ | An Inpatient Study of the Effectiveness and Safety of Depakote ER in the Treatment of Mania/Bipolar Disorder | Completed | Abbott | Phase 3 | 2003-01-01 | The purpose of this study is to determine the safety and effectiveness of Depakote ER compared to placebo in the treatment of bipolar disorder, manic or mixed type in adults. |
| NCT00063362 ↗ | Combination Therapy for the Treatment of Bipolar Disorders | Terminated | National Institute of Mental Health (NIMH) | Phase 3 | 2002-02-01 | This study will compare triple and double drug regimens in the treatment of patients with depression, hypomania, or mania. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for DEPAKOTE ER
Condition Name
Clinical Trial Locations for DEPAKOTE ER
Trials by Country
Clinical Trial Progress for DEPAKOTE ER
Clinical Trial Phase
Clinical Trial Sponsors for DEPAKOTE ER
Sponsor Name
